作者
Nagesh S Anavekar, John JV McMurray, Eric J Velazquez, Scott D Solomon, Lars Kober, Jean-Lucien Rouleau, Harvey D White, Rolf Nordlander, Aldo Maggioni, Kenneth Dickstein, Steven Zelenkofske, Jeffrey D Leimberger, Robert M Califf, Marc A Pfeffer
发表日期
2004/9/23
期刊
New England Journal of Medicine
卷号
351
期号
13
页码范围
1285-1295
出版商
Massachusetts Medical Society
简介
Background
The presence of coexisting conditions has a substantial effect on the outcome of acute myocardial infarction. Renal failure is associated with one of the highest risks, but the influence of milder degrees of renal impairment is less well defined.
Methods
As part of the Valsartan in Acute Myocardial Infarction Trial (VALIANT), we identified 14,527 patients with acute myocardial infarction complicated by clinical or radiologic signs of heart failure, left ventricular dysfunction, or both, and a documented serum creatinine measurement. Patients were randomly assigned to receive captopril, valsartan, or both. The glomerular filtration rate (GFR) was estimated by means of the four-component Modification of Diet in Renal Disease equation, and the patients were grouped according to their estimated GFR. We used a 70-candidate variable model to adjust and compare overall mortality and composite cardiovascular …
引用总数
20052006200720082009201020112012201320142015201620172018201920202021202220232024103163170184187184151163148155126118101101997588666627
学术搜索中的文章